COVID-19 and the ageing immune system in an elderly patient : a case report
Article Sidebar
Main Article Content
Abstract
Background
The severity of COVID-19 infection has an increasing trend in the elderly, which contributes to the high morbidity and mortality rates in this population. Aging itself is a prominent risk factor for severe disease and death from COVID-19.
Case Description
This case report a 71-year-old woman who complained of shortness of breath for 3 days before being admitted to the hospital. Bilateral consolidation and increased bronchovascular pattern were found on chest radiograph, and a positive SARS-COV2 nasopharyngeal swab PCR test result was noted. This patient was diagnosed with confirmed severe manifestation of COVID-19, community-acquired pneumonia and type 1 respiratory failure, as well as type II diabetes mellitus and suspicion of acute gastritis. The results of the geriatric status assessment were moderate functional status, risk of malnutrition, and moderate risk of deep vein thrombosis (DVT). This patient underwent treatment in accordance with the COVID-19 protocol along with management for geriatric status improvement. The patient was given permission to return home after 14 days of treatment, during which time her health had improved and her functional status had changed to moderate dependency. During follow-up, the patient continued to receive therapy. She is still being observed and future evaluations will be conducted.
Conclusion
The increased susceptibility of the elderly to COVID-19 infection is caused by various factors. A burden of death and long-term disability brought on by this pandemic may be lessened by new or modified therapies that target aging-associated mechanisms. Therefore, COVID-19 case management in this population should be done with a comprehensive approach.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.
References
Zhang X, Li S, Niu S. ACE2 and COVID-19 and the resulting ARDS. Postgrad Med J 2020;96:403–7. doi: 10.1136/postgradmedj-2020-137935.
Sieñko J, Kotowski M, Bogacz A, et al. COVID-19: the influence of ACE genotype and ACE-I and ARBs on the course of SARS-CoV-2 infection in elderly patients. Clin Interv Aging 2020;15:1231-40. doi: 10.2147/CIA.S261516.
CDC COVID-19 Response Team, Bialek S, Boundy E, Bowen V, et al. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) — United States, February 12–March 16, 2020. MMWR Morb Mortal Wkly Rep 2020;69:343-6. doi: 10.15585/mmwr.mm6912e2.
Karyono DR, Wicaksana AL. Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. JCEMPH 2020;3:77-84. DOI: 10.22146/jcoemph.57325.
Fulop T, Dupuis G, Witkowski JM, Larbi A. The role of immunosenescence in the development of age-related diseases. Rev Invest Clin 2016;68:84-91.
Jergoviæ M, Coplen CP, Uhrlaub JL, Nikolich-Žugich J. Immune response to COVID-19 in older adults. J Heart Lung Transplant 2021;40:1082-9. doi: 0.1016/j.healun.2021.04.017.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases From the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239–42. doi:10.1001/jama.2020. 2648.
Dhama K, Patel SK, Kumar R, et al. Geriatric population during the COVID-19 pandemic: problems, considerations, exigencies, and beyond. Front Public Health 2020;8:574198. doi: 10.3389/fpubh.2020.574198.
Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections? Front Physiol 2021;11: 571416. doi: 10.3389/fphys.2020.571416.
Perrotta F, Corbi G, Mazzeo G, et al. COVID-19 and the elderly: insights into pathogenesis and clinical decision-making. Aging Clin Exp Res 2020; 32:1599-608. doi: 10.1007/s40520-020-01631-y.
Malone ML, Hogan TM, Perry A, et al. COVID-19 in older adults: key points for emergency department providers. Geriatric Emergency Department Collaborative. J Geriatr Emerg Med 2020;1:1-11.
Torres Acosta MA, Singer BD. Pathogenesis of COVID-19-induced ARDS: implications for an ageing population. Eur Respir J 2020;56:2002049. doi: 10.1183/13993003.02049-2020.
Koff WC, Williams MA. Covid-19 and immunity in aging populations — a new research agenda. N Engl J Med 2020;383:804–5. doi: 10.1056/NEJMp2006761.
Bencivenga L, Rengo G, Varricchi G. Elderly at time of COrona Virus disease 2019 (COVID-19): possible role of immunosenescence and malnutrition. Geroscience 2020;42:1089-92. doi: 10.1007/s11357-020-00218-9.
Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients. J Infect 2020;80:e14-e8. doi: 10.1016/j.jinf.2020.03.005.
Heneghan C, Aronson J, Mahtani K. Rapidly managing pneumonia in older people during a pandemic. Oxford COVID-19 Centre for Evidence Based-Medicine; 2020.
Yang JW, Yang L, Luo RG, Xu JF. Corticosteroid administration for viral pneumonia: COVID-19 and beyond. Clin Microbiol Infect 2020;26:1171-7. doi: 10.1016/j.cmi.2020.06.020.
Matera MG, Rogliani P, Calzetta L, Cazzola M. Pharmacological management of COVID-19 patients with ARDS (CARDS): a narrative review. Respir Med 2020;171:106114. doi: 10.1016/j.rmed. 2020.106114.
Fischer F, Raiber L, Boscher C, Winter MHJ. COVID-19 and the elderly: who cares? Front Public Health 2020;8:151. doi: 10.3389/fpubh. 2020.00151.
Azzolino D, Saporiti E, Proietti M, Cesari M. Nutritional considerations in frail older patients with COVID-19. J Nutr Health Aging 2020;24:696–8. doi: 10.1007/s12603-020-1400-x.
Fernández-Quintela A, Milton-Laskibar I, Trepiana J, et al. Key Aspects in nutritional management of COVID-19 patients. J Clin Med 2020;9:2589. doi: 10.3390/jcm9082589.
Rolles B, Maywald M, Rink L. Influence of zinc deficiency and supplementation on NK cell cytotoxicity. J Funct Foods 2018;48:322-8. https://doi.org/10.1016/j.jff.2018.07.027.